Insider · CIK 0002032351
Annette Bruls
Files at EW (Edwards Lifesciences Corp). First filing Aug 28, 2026, latest Aug 28, 2026.
In brief
Annette Bruls files SEC Form 4 as officer at EW (Edwards Lifesciences Corp). Since Aug 28, 2026, Annette Bruls has reported 0 open-market buys worth $0 and 1 open-market sell worth $238k, the latest filed on Aug 28, 2026.
A track record needs three past buys with six months of prices behind them; Annette Bruls has 0, so none is measured yet.
The newest scored trade: sold $238k of EW on Aug 28, 2026, filed Aug 28, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $238k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EW: Edwards Lifesciences Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Edwards Lifesciences Corp | $238k 2,644 shares | -13% | +24% from low-5% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 28, 2026 | EW Edwards Lifesciences Corp | 2,644 0.00% of outstanding | $238k | Aug 28, 2026 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock | -2,644 | $89.98 | $238k | 17,984 | Aug 28, 2026 |
| Jul 11, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -109 | $92.21 | $10k | 20,628 | Jul 13, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +6,650 | $0.00 | $0 | 20,821 | May 8, 2026 |
| May 8, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -84 | $82.76 | $6,952 | 20,737 | May 8, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Employee Stock Option (Right to Acquire)derivative | +33,700 | $0.00 | $0 | 33,700 | May 8, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Performance Rightsderivative | +6,650 | $0.00 | $0 | 6,650 | May 8, 2026 |
| Jul 11, 2025 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -109 | $78.80 | $8,589 | 14,171 | Jul 11, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +6,200 | $0.00 | $0 | 14,280 | May 9, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Employee Stock Option (Right to Acquire)derivative | +31,600 | $0.00 | $0 | 31,600 | May 9, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Performance Rightsderivative | +6,200 | $0.00 | $0 | 6,200 | May 9, 2025 |
Questions about Annette Bruls
Answered from the filings on this page, as of the latest one.
Is Annette Bruls buying or selling?
In the last 12 months Annette Bruls reported 0 open-market buys worth $0 and 1 open-market sell worth $238k on SEC Form 4; the latest was sold $238k of EW on Aug 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Annette Bruls's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Annette Bruls has 0.
Where does Annette Bruls file Form 4?
Annette Bruls has filed Form 4 at EW (Edwards Lifesciences Corp) as CVP, EMEACLA. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.